Aforé by Dr. Few announced the publication of the first-ever clinical study on the effects of a retinol and cannabidiol (CBD) combination in topical skincare by the Aesthetic Surgery Journal.The novel peer-reviewed study by Dr. Few finds Aforé’s CR Emulsion is effective at improving global skin quality, including static and dynamic wrinkles, without the side effects of traditional retinol solutions. By adding CBD, an anti-inflammatory ingredient, to the base 0.2 percent retinol solution, it maintains the anti-aging properties, but with reduced side effects.
The CR Emulsion product was designed by combining ingredients which act on complementary biochemical pathways important in maintaining the skin’s health and preventing aging. Combining solubilized CBD and retinol, along with other botanicals, allow retinol to improve cellular turnover and decrease the depth of fine lines and wrinkles, while solubilized, medical-grade CBD counteracts irritating effects, like redness or peeling. In the study, 10 patients applied the CR Emulsion nightly for six weeks. Patients reported improvement in every area, but the greatest improvements were for visible pores, dehydration, surface roughness, static wrinkles, and dynamic wrinkles.
Related Articles
Aforé Launches CBD Face Cream With Retinol
Aforé by Dr. Few Unveils Physician-Formulated CBD Mist